Efficacy of the injectable calcium phosphate ceramics suspensions containing magnesium, zinc and fluoride on the bone mineral deficiency in ovariectomized rats

Journal of Pharmaceutical Sciences

Volumn 97, Issue 1, 2008, Pages 421-432

  Otsuka, Makoto ^a   Oshinbe, Ayako ^b   Legeros, Racquel Z ^c   Tokudome, Yoshihiro ^a   Ito, Atsuo ^d   Otsuka, Kuniko ^e   Higuchi, William I ^f  

^a MUSASHINO UNIVERSITY   (Japan)

^b KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

^c NEW YORK UNIVERSITY   (United States)

^d NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^e SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f UNIVERSITY OF UTAH   (United States)

Author keywords

Bone properties; Calcium phosphates; Fluoride; Magnesium; OVX rats; Zinc

Indexed keywords

CALCIUM PHOSPHATE CERAMIC; FLUORIDE; MAGNESIUM; ZINC;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; BONE DEMINERALIZATION; BONE DENSITY; DISSOLUTION; DRUG BLOOD LEVEL; DRUG EFFICACY; DUAL ENERGY X RAY ABSORPTIOMETRY; IN VITRO STUDY; NONHUMAN; OSTEOPOROSIS; RAT; X RAY DIFFRACTION;

EID: 38349181600     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21131     Document Type: Article

References (33)

1. Williams RJP. 1984. Zinc: What is its role in biology? Endeavour 8:65-70.
2. Kishi S, Yamaguchi M. 1994. Inhibitory effect of zinc compounds on osteoblast-like cell formation in mouse marrow cultures. Biochem Pharmacol 48: 1225-1230.
3. Szathmari M, Steczek K, Szucs J, Hollo I. 1993. Zinc excretion in osteoporotic women. Orv Hetil 134:911-914.
4. Relea P, Revilla M, Pipoll E, Arribas I, Villa LF, Rico H. 1995. Zinc, biochemical markers of nutrition, and type I osteoporosis. Age Aging 24:303-307.
5. Daculsi G, Bouler JM, LeGeros RZ. 1997. Adaptive crystal formation in normal and pathological calcifications in synthetic calcium phosphate and related biomaterials. Int Rev Cytol 172:129-191.
6. LeGeros RZ. 1991. Calcium phosphates in oral biology and medicine. In: Myers HM, editor. Monographs in oral sciences. Vol. 15. Basel: Karger.
7. Ito A, Naito H, Ichinose N, Tateish T. 2000. Preparation, solubility and cytocompatibility of zinc-releasing calcium phosphate ceramics. J Biomed Mater Res 50:178-183.
8. Kawamura H, Ito A, Miyakawa S, Layrolle P, Ojima K, Naito H, Ichinose N, Tateishi T. 2000. Stimulatory effect of zinc on bone formation around zinc-releasing calcium phosphate ceramics implanted rabbits femora. J Biomed Mater Res 50:184-190.
9. Otsuka M, Marunaka S, Matsuda Y, Ito A, Layrolle P, Naito H, Ichinose N. 2000. Calcium level-responsive in-vitro zinc release from zinc containing tricalcium phosphate (Zn-TCP). J Biomed Mater Res 52:819-824.
10. Otsuka M, Marunaka S, Matsuda Y, Ito A, Naito H, Ichinose N, Kokubo T, Nakamura T, Higuchi WI. 2003. Effect of particle size on zinc release from zinc containing tricalcium phosphate (Zn-TCP) in Zn-deficient osteoporosis rats. Biomed Mater Eng 13:103-113.
11. Otsuka M, Ohshita Y, Marunaka S, Matsuda Y, Ito A, Ichinose N, Otsuka K, Higuchi WI. 2004. Effect of controlled zinc release on bone mineral density from injectable Zn-containing-tricalcium phosphate suspension in zinc-deficient diseased rats. J Biomed Mater Res 69A:552-560.
12. Ito A, Otsuka M, Kawamura H, Ikeuchi M, Ohgushi H, Sogo Y, Ichinose N. 2005. Zinc-containing tricalcium phosphate and related materials for promoting bone formation. Curr Appl Phys 5: 402-406.
13. Haguenauer D, Welch V, Shea B, Tugwell P, Adachi JD, Wells G. 2000. Fluoride for the treatment of postmenopausal osteoporotic fractures: A meta-analysis. Osteoporos Int 11:727-738.
14. Ingram GS, Nash PF. 1980. A mechanism for the anticaries action of fluoride. Caries Res 14:298-303.
15. Kleerelopper M. 1996. Fluoride and the skeleton. In: Bilezikian JP, Raisz LG, Rodan GA, editors. Principles of bone biology. Chapter 75. San Diego: Academic Press. pp 1053-1062.
16. LeGeros RZ, Sakae T, Batista C, Retino M, LeGeros JP. 1996. Magnesium and carbonate in enamel and synthetic apatites. Adv Dent Res 10: 225-231.
17. Daculsi G, Bouler JM, LeGeros RZ. 1997. Adaptive crystal formation in normal and pathological calcifications in synthetic calcium phosphate and related biomaterials. Int Rev Cytol 172:129-191.
18. LeGeros RZ. NIBIB/NIH Research Grant No. R01 EB003070. "Biomaterials (Mg/Zn/F-CaP) for Osteoporosis Therapy" funded 2003-2007.
19. Otsuka M, Oshinbe A, Ito A, Otsuka K, Higuchi WI, LeGeros RZ. 2006. Therapeutic effect of selected biomaterials (Mg/Z/F-CaPs) administered by injection on bone properties of ovariectomized rats. Key Eng Mater 309-311:243-246.
20. LeGeros RZ. NIBIB/NIH Research Grant No. RO1 EB 003070 Progress Reports, 2004, 2005.
21. Kitano M, Ueda J. 1971. Calcium spectrophotometric determination by the methylxyenol blue formed a complex. Nippon Kagaku Kaishi 92:168-170.
22. Yamaguchi M, Kishi S. 1993. Prolonged administration of b-alanyl-L-histidinato zinc prevents bone loss in ovariectomized rats, Japan. J Pharmacol 63:203-207.
23. Suda T, DeLuca HF, Tanaka Y. 1970. Biological activity of 25-hydroxyergocalciferol in rats. J Nutr 100:1049-1052.
24. Kind PRN, King EJ. 1954. Measurement of alkaline phosphatase. J Clin Path 7:322-326.
25. Baron R. 1989. Molecular mechanisms of bone resorption by the osteoclast. Anat Rec 224:317-324.
26. +) ATPase in the plasma membrane of the osteoclast. Cell 46:311-320.
27. Otsuka M, Teraoka R, Matsuda Y. 1991. Physicochemical properties of nitrofurantoin anhydrate and monohydrate and their dissolution. Chem Pharm Bull 39:2667-2670.
28. Okano T, Kimura T, Tsugawa N, Fujiwara M, Yamamoto M, Kobayashi T. 1994. Bioavailability of calcium from bovine-bone-marrow calcium (BBMCa) and calcium carbonate in Vitamin D-deficient rats. Food Chem 51:61-67.
29. Okano T, Kimura N, Tsugawa Y, Okamura Y, Kobayashi T. 1994. Roles of parathyroid hormone and 1a,25-dihydroxyvitamin D3 in bone growth of growing male and female rats. J Bone Miner Metab S23-S26.
30. LeGeros RZ. 1984. Incorporation of magnesium in synthetic and biologic apatites. In: Fearnhead RW, Suga S, editors. Tooth enamel IV. Amsterdam: Elsevier Science Publishers BV. pp 32-36.
31. Okazaki M, LeGeros RZ. 1992. Crystallogaphic and chemical properties of Mg-containing apatites before and after suspension in solutions. Magnesium Res 5:103-108.
32. Ito A, Senda K, Sogo Y, Oyane A, Yamazaki A, LeGeros RZ. 2006. Dissolution rate of zinc-containing β-Rricalcium phosphate ceramics. Biomed Mater 1:134-139.
33. Baig A, Fox JL, Young RA, Wang Z, Hsu J, Higuchi WI, Chhettry A, Zhuang H, Otsuka M. 1999. Relationships amount carbonated apatite solubility, crystallite size, and microstrain parameters, calcif. Tissue Int 64:437-449.